Occudo Quantitative Strategies LP Nuvation Bio Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.56 - $1.84 $49,587 - $58,488	-31,787 Reduced 59.84%	21,331 $38,000
Q1 2023 May 15, 2023	SELL	$1.6 - $2.48 $6,532 - $10,125	-4,083 Reduced 7.14%	53,118 $88,000
Q4 2022 Feb 14, 2023	SELL	$1.68 - $2.5 $13,692 - $20,375	-8,150 Reduced 12.47%	57,201 $109,000
Q3 2022 Nov 14, 2022	SELL	$0.29 - $4.04 $6,291 - $87,651	-21,696 Reduced 24.92%	65,351 $146,000
Q2 2022 Aug 15, 2022	SELL	$3.24 - $5.85 $80,620 - $145,565	-24,883 Reduced 22.23%	87,047 $282,000
Q1 2022 May 16, 2022	BUY	$4.6 - $8.83 $514,877 - $988,341	111,930 New	111,930 $589,000

152

123M

9.7K

6.5K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $480M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.